Development
Cognex Corporation
CGNX
$41.36
$0.471.15%
NASDAQ
| 12/31/2023 | 10/01/2023 | 07/02/2023 | 04/02/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 837.55M | 880.31M | 892.69M | 924.81M | 1.01B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 837.55M | 880.31M | 892.69M | 924.81M | 1.01B |
| Cost of Revenue | 236.31M | 244.55M | 247.47M | 262.78M | 284.19M |
| Gross Profit | 601.24M | 635.76M | 645.23M | 662.03M | 721.91M |
| SG&A Expenses | 339.14M | 324.72M | 317.78M | 314.31M | 312.11M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 714.85M | 711.11M | 708.46M | 720.71M | 737.43M |
| Operating Income | 122.70M | 169.20M | 184.23M | 204.10M | 268.67M |
| Income Before Tax | 135.35M | 180.23M | 192.57M | 189.21M | 250.70M |
| Income Tax Expenses | 22.11M | 22.91M | 20.19M | 15.40M | 35.17M |
| Earnings from Continuing Operations | 113.23 | 157.32 | 172.38 | 173.81 | 215.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 113.23M | 157.32M | 172.38M | 173.81M | 215.53M |
| EBIT | 122.70M | 169.20M | 184.23M | 204.10M | 268.67M |
| EBITDA | 144.58M | 189.16M | 203.94M | 223.69M | 288.29M |
| EPS Basic | 0.66 | 0.91 | 1.00 | 1.00 | 1.24 |
| Normalized Basic EPS | 0.46 | 0.64 | 0.71 | 0.76 | 0.98 |
| EPS Diluted | 0.65 | 0.91 | 0.99 | 1.00 | 1.23 |
| Normalized Diluted EPS | 0.46 | 0.64 | 0.70 | 0.76 | 0.97 |
| Average Basic Shares Outstanding | 688.99M | 689.92M | 691.00M | 692.08M | 693.60M |
| Average Diluted Shares Outstanding | 693.45M | 694.78M | 695.76M | 697.13M | 699.89M |
| Dividend Per Share | 0.29 | 0.28 | 0.28 | 0.27 | 0.27 |
| Payout Ratio | 43.34% | 30.70% | 27.56% | 26.87% | 21.31% |